Practical approaches to diagnosing PitNETs/adenomas based on cell lineage

Author:

Goyal‐Honavar Abhijit1ORCID,Chacko Geeta2ORCID

Affiliation:

1. Department of Neurosurgery National Institute of Mental Health and Neurosciences (NIMHANS) Bengaluru India

2. Neuropathology, Department of Pathology Christian Medical College Vellore India

Abstract

AbstractThe evolution of classification systems of pituitary adenomas (now PitNETs) has culminated in the use of transcription factor (TF) immunohistochemistry (IHC), forming a cell lineage‐based system. However, several issues remain to be addressed, including the additional financial and logistic burden of undertaking the complete array of anterior pituitary hormones and TF IHC. To that end, several groups have suggested algorithms to minimise the number of tests performed, with varying levels of diagnostic accuracy. Although the proportion of null cell tumours has decreased following the use of TFs, “multilineage” tumours have been reported and characterised using transcriptomic signatures, most prominently the PIT1‐SF1 co‐expressing PitNETs, which do not bear a position in the present system of classification. In this review, we examine the proposed practical approaches to the diagnosis of PitNETs. We review the literature on reported PitNET types that challenge the existing classification system, such as those that express multiple TFs, with their potential clinical implications. Finally, we assess limitations in the present system, such as the lack of a standardised system for IHC interpretation, that need to be addressed in the future.

Publisher

Wiley

Reference26 articles.

1. Brat DJ Lopes MB Mete O Osamura RY Asa SL Kleinschmidt‐DeMasters BK et al. Pituitary adenoma/Pituitary Neuroendocrine Tumour. In: WHO Classification of Tumours Editorial Board. Central nervous system tumours. [Internet] Lyon (France): International Agency for Research on Cancer; 2021. [cited 2022 Jan 31]. (WHO classification of tumours series 5th ed.; Vol. 6). Available from:https://tumourclassification.iarc.who.int/chapters/45

2. Pituitary neuroendocrine tumor: is it benign or malignant?;Lee CH;Brain Tumor Res Treat,2023

3. Epidemiology and biomarker profile of pituitary adenohypophysial tumors

4. Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3